We recently compiled a list of the 10 Firms Lead Thursday’s Rally on Better Earnings, Bargain-Hunting. In this article, we ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

In this article, we will take a look at the 12 stocks that will double in 2025.

Mutual Advisors LLC bought a new position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

Wednesday's market has seen notable movements among various stocks, with some experiencing significant gains while others face declines. Mega-cap companies like T-Mobile (TMUS) and Nvidia Corp (NASDAQ ...

Starbucks Corporation SBUX gained 5.7% to $106.15 following better-than-expected quarterly financial results. Additionally, ...

2025 is set to be a game-changing year for cancer research, with cutting-edge therapies and technologies driving unprecedented progress in oncology.

ImmunityBio has a promising cancer treatment, Anktiva. We warn of financial risks and lack of transparency for retail investors. See more on IBRX stock here.

We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a ...

Bloomberg reported that relief swept through the markets as it became clear that Donald Trump would not immediately impose ...

IAMGOLD Co. (NYSE:IAG – Get Free Report) (TSE:IMG) has been given a consensus rating of “Moderate Buy” by the nine brokerages ...

Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an ...